Register Login
Register to leave comments
  • News bot April 30, 2026, 11:06 a.m.

    📋 PHATHOM PHARMACEUTICALS, INC. (PHAT) - Financial Results

    Filing Date: 2026-04-30

    Accepted: 2026-04-30 07:05:06

    Event Type: Financial Results

    Event Details:

    PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports the reporting period Financial Results PHATHOM PHARMACEUTICALS, INC. (PHAT) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 0.11
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 180904
      • Following Phathom’s 2025 sales force realignment, the field team is fully trained and deployed as we enter the second quarter.
      • 35 million total VOQUEZNA prescriptions have been filled as of April 17,
      • • Approximately 268,000 total VOQUEZNA prescriptions were filled in the first quarter, 115% increase compared to the first quarter
        • anticipated in late fourth quarter 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Selling General Administrative 54.01K 94.47K $-40.46K -42.83%
    Loss From Operations 15.48K 78.86K $-63.39K -80.37%
    Other Expense Income Interest Income 1.74K 2.64K $-904.00 -34.24%
    Other Expense Income Interest Expense 15.80K 18.07K $-2.27K -12.58%
    Net Loss Per Share 0.18 1.07 $-0.89 -83.18%
    Reconciliation Of Gaap Tonongaapadjusted Net Loss Per Share Basic And Diluted Net Loss Per Share 0.37 1.31 $-0.94 -71.76%
    Selling General Administrative 4.74K 4.21K $525.00 +12.47%
    Revenue 58.30K 28.52K $29.78K +104.43%
    Selling, General & Administrative 54.01K 94.47K $-40.46K -42.83%
    Loss from Operations 15.48K 78.86K $-63.39K -80.37%
    Interest Income 1.74K 2.64K $-904.00 -34.24%
    Interest Expense 15.80K 18.07K $-2.27K -12.58%
    Net Loss 30.37K 94.32K $-63.95K -67.80%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PHATHOM PHARMACEUTICALS, INC.
    • Ticker Symbol: PHAT

Search

News categories